Effect of autolymphocyte therapy on survival and quality of life in patients with metastatic renal-cell carcinoma
Open Access
- 28 April 1990
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 335 (8696), 994-998
- https://doi.org/10.1016/0140-6736(90)91064-h
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- A Randomized Trial Comparing Combination Electron-Beam Radiation and Chemotherapy with Topical Therapy in the Initial Treatment of Mycosis FungoidesNew England Journal of Medicine, 1989
- Effect of protaglandin E in multiple experimental models. VI. Effects on T-cell subsetsProstaglandins, 1989
- T-Cell Tumor Elimination as a Result of T-Cell Receptor-Mediated ActivationScience, 1987
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- On Lymphokines, Cytokines, and BreakthroughsPublished by American Medical Association (AMA) ,1986
- Successful adoptive immunotherapy of metastatic renal cell carcinoma with in vitro immunized autologous lymphocytes and cimetidineWorld Journal of Urology, 1986
- Antigen-driven long term-cultured T cells proliferate in vivo, distribute widely, mediate specific tumor therapy, and persist long-term as functional memory T cells.The Journal of Experimental Medicine, 1986
- Pharmacologic effects of autacoids on subsets of T cells. Regulation of expression/function of histamine-2 receptors by a subset of suppressor cells.JCI Insight, 1985
- Biologicals and Biological Response Modifiers: New Approaches to Cancer TreatmentCancer Investigation, 1985